Your browser doesn't support javascript.
A two-ward acute care hospital outbreak of SARS-CoV-2 delta variant including a point-source outbreak associated with the use of a mobile vital signs cart and sub-optimal doffing of personal protective equipment.
O'Grady, H M; Harrison, R; Snedeker, K; Trufen, L; Yue, P; Ward, L; Fifen, A; Jamieson, P; Weiss, A; Coulthard, J; Lynch, T; Croxen, M A; Li, V; Pabbaraju, K; Wong, A; Zhou, H Y; Dingle, T C; Hellmer, K; Berenger, B M; Fonseca, K; Lin, Y-C; Evans, D; Conly, J M.
  • O'Grady HM; Infection Prevention and Control, Alberta Health Services, Calgary, Alberta, Canada.
  • Harrison R; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Workplace Health and Safety, Alberta Health Services, Edmonton, Alberta, Canada.
  • Snedeker K; Provincial Population and Public Health, Alberta Health Services, Calgary, Alberta, Canada.
  • Trufen L; Workplace Health and Safety, Alberta Health Services, Edmonton, Alberta, Canada.
  • Yue P; Infection Prevention and Control, Alberta Health Services, Calgary, Alberta, Canada.
  • Ward L; Infection Prevention and Control, Alberta Health Services, Calgary, Alberta, Canada.
  • Fifen A; Infection Prevention and Control, Alberta Health Services, Calgary, Alberta, Canada.
  • Jamieson P; Department of Family Medicine, University of Calgary and Alberta Health Services, Calgary, Alberta, Canada; Site Administration, Foothills Medical Centre, Alberta Health Services, Calgary, Alberta, Canada.
  • Weiss A; Site Administration, Foothills Medical Centre, Alberta Health Services, Calgary, Alberta, Canada.
  • Coulthard J; Site Administration, Foothills Medical Centre, Alberta Health Services, Calgary, Alberta, Canada.
  • Lynch T; Department of Pathology & Laboratory Medicine, University of Calgary and Alberta Health Services, Calgary, Alberta, Canada; Genomics and Bioinformatics, Alberta Public Health Laboratory, Alberta Precision Laboratories, Calgary, Alberta, Canada; Alberta Public Health Laboratory, Alberta Precision
  • Croxen MA; Alberta Public Heath Laboratory, Alberta Precision Laboratories, Edmonton, Alberta, Canada; Department of Laboratory Medicine, University of Alberta, Edmonton, Alberta, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada.
  • Li V; Alberta Public Heath Laboratory, Alberta Precision Laboratories, Edmonton, Alberta, Canada.
  • Pabbaraju K; Alberta Public Health Laboratory, Alberta Precision Laboratories, Calgary, Alberta, Canada.
  • Wong A; Alberta Public Health Laboratory, Alberta Precision Laboratories, Calgary, Alberta, Canada.
  • Zhou HY; Alberta Public Health Laboratory, Alberta Precision Laboratories, Calgary, Alberta, Canada; Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
  • Dingle TC; Department of Pathology & Laboratory Medicine, University of Calgary and Alberta Health Services, Calgary, Alberta, Canada; Alberta Public Health Laboratory, Alberta Precision Laboratories, Calgary, Alberta, Canada.
  • Hellmer K; Site Administration, Foothills Medical Centre, Alberta Health Services, Calgary, Alberta, Canada.
  • Berenger BM; Department of Pathology & Laboratory Medicine, University of Calgary and Alberta Health Services, Calgary, Alberta, Canada; Alberta Public Health Laboratory, Alberta Precision Laboratories, Calgary, Alberta, Canada.
  • Fonseca K; Alberta Public Health Laboratory, Alberta Precision Laboratories, Calgary, Alberta, Canada; Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
  • Lin YC; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Alberta, Canada.
  • Evans D; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada; Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Alberta, Canada.
  • Conly JM; Infection Prevention and Control, Alberta Health Services, Calgary, Alberta, Canada; Department of Pathology & Laboratory Medicine, University of Calgary and Alberta Health Services, Calgary, Alberta, Canada; Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary,
J Hosp Infect ; 131: 1-11, 2022 Oct 03.
Article in English | MEDLINE | ID: covidwho-2243844
ABSTRACT

BACKGROUND:

The arrival of the Delta variant of SARS-CoV-2 was associated with increased transmissibility and illness of greater severity. Reports of nosocomial outbreaks of Delta variant COVID-19 in acute care hospitals have been described but control measures varied widely.

AIM:

Epidemiological investigation of a linked two-ward COVID-19 Delta variant outbreak was conducted to elucidate its source, risk factors, and control measures.

METHODS:

Investigations included epidemiologic analysis, detailed case review serial SARS-CoV-2 reverse transcriptase-polymerase chain reaction (RT-PCR) testing of patients and healthcare workers (HCWs), viral culture, environmental swabbing, HCW-unaware personal protective equipment (PPE) audits, ventilation assessments, and the use of whole genome sequencing (WGS).

FINDINGS:

This linked two-ward outbreak resulted in 17 patient and 12 HCW cases, despite an 83% vaccination rate. In this setting, suboptimal adherence and compliance to PPE protocols, suboptimal hand hygiene, multi-bedded rooms, and a contaminated vital signs cart with potential fomite or spread via the hands of HCWs were identified as significant risk factors for nosocomial COVID-19 infection. Sudden onset of symptoms, within 72 h, was observed in 79% of all Ward 2 patients, and 93% of all cases (patients and HCWs) on Ward 2 occurred within one incubation period, consistent with a point-source outbreak. RT-PCR assays showed low cycle threshold (CT) values, indicating high viral load from environmental swabs including the vital signs cart. WGS results with ≤3 SNP differences between specimens were observed.

CONCLUSION:

Outbreaks on both wards settled rapidly, within 3 weeks, using a `back-to-basics' approach without extraordinary measures or changes to standard PPE requirements. Strict adherence to recommended PPE, hand hygiene, education, co-operation from HCWs, including testing and interviews, and additional measures such as limiting movement of patients and staff temporarily were all deemed to have contributed to prompt resolution of the outbreak.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Language: English Journal: J Hosp Infect Year: 2022 Document Type: Article Affiliation country: J.jhin.2022.09.019

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Language: English Journal: J Hosp Infect Year: 2022 Document Type: Article Affiliation country: J.jhin.2022.09.019